ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today released its bi-annual product performance report (PPR) on its website, sjmprofessional.com.
CHICAGO (Reuters) - St. Jude Medical Inc said on Monday initial findings from a study on its Riata defibrillator leads, which were recalled in late 2011, showed that lead erosion that occurred from ...
> An independent study has concluded that St. Jude Medical's ($STJ) now-recalled Riata defibrillator leads had a much worse survival rate than the Quattro lead ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback